Overview: Limitations of Current Treatment of Depression
Mar 24, 2016 - 26:10
Radio and PodcastLive Radio & PodcastsScience & Medicine
Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia
Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Freudenreich, MD, FAPM
About This Episode
Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia is an episode from MGH Psychiatry Academy Podcasts by MGH Academy. Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Fr...
Podcast
This episode belongs to MGH Psychiatry Academy Podcasts.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Mar 24, 2016, 43:25 long, audio available.
Related Episodes
Continue listening to more episodes from MGH Psychiatry Academy Podcasts.
Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia
Mar 24, 2016 - 53:33
Assessment and Treatment of Affective Symptoms in Schizophrenia
Mar 24, 2016 - 48:28
Optimal Treatment of Psychosis in Bipolar Disorder
Mar 24, 2016 - 19:56
Early Detection and Intervention in Bipolar Disorder and Schizophrenia
Mar 24, 2016 - 45:38
Anxiety and Depression: Pharmacological Approaches
Jun 16, 2014 - 35:58
Anxiety in the Setting of Depression: Risk, Comorbidity, and Residual Symptoms
Jun 16, 2014 - 46:51
Cognitive Dysfunction in Depressed Patients
Jun 16, 2014 - 44:00